CRISPR therapy - revolution in medicine or ethical danger
DOI:
https://doi.org/10.12775/QS.2026.49.67138Keywords
CRISPR, clustered regularly interspaced short palindromic repeats, CRISPR-Cas9, ethical implications, moral challenges, genetics, modern genetics, innovative medicine, progressive medicineAbstract
CRISPR, or rather rarely used full name – Clustered Regularly Interspaced Short Palindromic Repeats. Studying this family of DNA sequences has led to the creation of CRISPR-Cas9 technology for genome editing. This technology has been with us for quite some time and is undeniably considered one of the most significant breakthroughs in modern genetics. It provides a powerful weapon for editing genomes with unprecedented precision, which can be used for advancing biotechnological inventions, finding and deploying new treatments and for overall progress in medicine. Recently, spikes of progress have been seen, which unquestionably have sparked many ethical and moral discussions about this technology. This paper examines the revolutionary potential of CRISPR therapy in medicine, alongside the ethical and moral implications that arise from its application. The potential of the therapy has been placed in a specialised context – how the implementation of CRISPR-Cas9 could impact sportsmen and -women, especially those battling such hard genetic diseases as Paralympians in different disciplines do every day. By analysing the scientific advancements, potential applications, and ethical dilemmas, a comprehensive understanding of CRISPR’s impact on contemporary medicine and contemporary sports is developed.References
1. Araldi, Rodrigo Pinheiro et al., ‘Medical applications of clustered regularly interspaced short palindromic repeats (CRISPR/Cas) tool: A comprehensive overview’ (2020) Gene 745;
2. Maier, Lisa-Katharina et al., ‘An active immune defence with a minimal CRISPR (clustered regularly interspaced short palindromic repeats) RNA and without the Cas6 protein’ (2015) The Journal of Biological Chemistry 290(7), 4192-4201;
3. Ansori, Arif N. et al., ‘Application of CRISPR-Cas9 genome editing technology in various fields: A review’ (2023) Narra J 3(2), e184;
4. Doudna, Jennifer A. and Emmanuelle Charpentier, ‘The new frontier of genome engineering with CRISPR-Cas9’ (2014) Science 346(6213);
5. Saeed, Sumbul et al., ‘Genome Editing Technology: A New Frontier for the Treatment and Prevention of Cardiovascular Diseases’ (2023) Current Problems in Cardiology 48(7);
6. Bansal, Mayank et al., ‘CRISPR Cas9 based genome editing in inherited retinal dystrophies’ (2021) Ophthalmic Genetics 42(4), 365–374;
7. Askitopoulou, Helen and N. Vgontzas, Antonis, ‘The Relevance of the Hippocratic Oath to the Ethical and Moral Values of Contemporary Medicine. Part II: Interpretation of the Hippocratic Oath – Today’s Perspective’ (2018) European Spinal Journal 27:1491-1500;
8. Knoppers, Bartha Maria and Kleiderman, Erika, ‘”CRISPR babies”: What does this mean for science and Canada?’ (2019) Canadian Medical Association Journal 191(4), E91–E92;
9. Eysenbach, Gunther et al., ‘Assessing Public Opinion on CRISPR-Cas9: Combining Crowdsourcing and Deep Learning’ (2020) Journal of Medical Internet Research 22(8);
10. Lorenzo, David et al., ‘Ethics and Genomic Editing Using the CRISPR-Cas9 Technique: Challenges and Conflicts’ (2022) NanoEthics: Studies of New and Emerging Technologies 16(3), 313–321;
11. Sprink, Thorben and Wilhelm, Ralf and Hartung, Frank, ‘Genome editing around the globe: An update on policies and perceptions’ (2022) Plant physiology, 190(3), 1579–1587;
12. D’Souza, Russel Franco et el., ‘Attitudes of Algorithms: An Exploration of the Ethics of CRISPR Cas9 through the Lens of ChatGPT’ (2024) Indian Journal of Clinical Biochemistry 1–8;
13. Watters, Kyle E. et al., ‘The CRISPR revolution and its potential impact on global health security’ (2021) Pathogens and global health, 115(2), 80–92;
14. Janik, Edyta et al., ‘Various Aspects of a Gene Editing System – CRISPR-Cas9’ (2020) International Journal of Molecular Sciences 21(24);
15. Schuijff, Mirjam et al., ‘A Q methodology study on divergent perspectives on CRISPR-Cas9 in the Netherlands’ (2021) BMC Medical Ethics 22(1);
16. Park, So Hyun and Gang, Bao, ‘CRISPR/Cas9 gene editing for curing sickle cell disease’ (2021) Transfusion and apheresis science 60(1), 1-18;
17. Zhang, Yi-ran et al., ‘CRISPR/Cas9 technology: applications in oocytes and early embryos’ (2023) Journal of Translational Medicine 21(1), 1–11;
18. Barman, Antara et al., ‘A glance at genome editing with CRISPR-Cas9 technology’ (2020) Current Genetics 66(3), 447–462;
19. Vermersch, Eva et al., ‘CRISPR/Cas9 gene-editing strategies in cardiovascular cells’ (2020) Cardiovascular Research 116(5), 894–90;
20. Ajaz A. Bhat et al., ‘Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics’ (2022) Journal of Translational Medicine 20(1), 1–18;
21. Quazi, Sameer, ‘Elucidation of CRISPR-Cas9 application in novel cellular immunotherapy’ (2022) Molecular Biology Reports 49(7), 7069–7077;
22. Tyagi, Swati et al., ‘CRISPR-Cas9 system: A genome-editing tool with endless possibilities’ (2020) Journal of Biotechnology 319, 36–53;
23. Oligonucleotide Therapeutics Society, ‘Can There Be International Agreement on How to Navigate the Future of Genome Editing?’ (5 April 2023) https://www.oligotherapeutics.org/can-there-be-international-agreement-on-how-to-navigate-the-future-of-genome-editing/);
24. World Anti-Doping Agency (WADA), Gene doping detection by next generation sequencing (2016) https://www.wada-ama.org/en/resources/scientific-research/gene-doping-detection-next-generation-sequencing;
25. Pray, Leslie, Sports, gene doping, and WADA (2008) Nature Education 1(1), 77;
26. Brownlee, C., Gene doping: Will athletes go for the ultimate high? (2004) Science News 166, 280;
27. Skipper, M., Gene doping: A new threat for the Olympics? (2004) Nature Reviews Genetics 5, 720;
28. Vandekerckhove, Ines et al., Muscle weakness but also contractures contribute to the progressive gait pathology in children with Duchenne muscular dystrophy: A simulation study (2025) J Neuroeng Rehabil. 22(1), 103;
29. Marcellini, Anne, The extraordinary development of sport for people with dis/abilities (2018) European Journal of Disability Research 12-2, 94-104;
30. Jelkmann, Wolfgang and Carsten Lundby, Blood doping and its detection (2011) American Society of Hematology 188(9), 2395-2404;
31. Mazzeo, Filomena, From gene doping to athlete biological passport (2016) Sport Science 9(2);
32. Raposo, Vera Lucia, A Room with a View (and with a Gene Therapy Drug): Gene Therapy Medicinal Products and Genetic Tourism in Europe (2022) Eur J Health Law 29(3-5), 504-520.
33. Chen, Yuan-Chuan, ‘CRISPR technology : recent advances’ (IntechOpen, 2023);
34. Singh, Vijai, ‘Reprogramming the genome: CRISPR-cas-based human disease therapy’ (Academic Press, 2021);
35. National Academies Press (US), ‘Human Genome Editing: Science, Ethics, and Governance’ (Washington, 2017);
36. Jamal, Muhammad, ‘The CRISPR/Cas system: emerging technology and application’ (Caister Academic Press, 2017).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Adrianna Mielżyńska, Mikołaj Pograniczny, Marcelina Nalepka, Jakub Pochopień, Adrianna Pacołta, Jędrzej Golec, Aleksandra Nowicka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 55
Number of citations: 0
